[go: up one dir, main page]

SI9500270B - Rekombinantni mersacidin in postopek za izdelavo - Google Patents

Rekombinantni mersacidin in postopek za izdelavo Download PDF

Info

Publication number
SI9500270B
SI9500270B SI9500270A SI9500270A SI9500270B SI 9500270 B SI9500270 B SI 9500270B SI 9500270 A SI9500270 A SI 9500270A SI 9500270 A SI9500270 A SI 9500270A SI 9500270 B SI9500270 B SI 9500270B
Authority
SI
Slovenia
Prior art keywords
amino acid
dna
premersacidin
mersacidin
promersacidin
Prior art date
Application number
SI9500270A
Other languages
English (en)
Other versions
SI9500270A (en
Inventor
Klaus-Peter Koller
Hans Georg Sahl
Gabriele Bierbaum
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Publication of SI9500270A publication Critical patent/SI9500270A/sl
Publication of SI9500270B publication Critical patent/SI9500270B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Claims (7)

  1. PATENTNI ZAHTEVKI 1. DNA, označena s tem, da kodira premersacidin z aminokislinsko sekvenco, prikazano na sl. 2, od aminokisline št. 1 do 68 (SEQ ID NO: 1).
  2. 2. DNA, označena s tem, da kodira premersacidin z nukleinsko kislinsko sekvenco, kot je prikazana na sl. 2, od nukleinske kisline št. 22 do 225 (SEQ ID NO: 3).
  3. 3. DNA, označena s tem, da kodira promersacidin z aminokislinsko sekvenco, prikazano na sl. 2, od aminokisline št. 49 do 68 (SEQ ID NO: 2).
  4. 4. DNA, označena s tem, da kodira promersacidin z nukleinsko kislinsko sekvenco, kot je prikazana na sl. 2, od nukleinske kisline št. 166 do 225 (SEQ ID NO: 4).
  5. 5. Vektor, označen s tem, da vsebuje DNA po enem od zahtevkov 1, 2, 3 ali 4.
  6. 6. Gostiteljska celica, označena s tem, da vsebuje vektor po zahtevku 5.
  7. 7. Postopek za izdelavo premersacidina, promersacidina ali zrelega mersacidina, označen s tem, da obsega stopnje: (a) kultiviranje prikladne gostiteljske celice, ki vsebuje DNA sekvenco po zahtevkih 1-4, pri prikladnih pogojih; in (b) izoliranje premersacidina, promersacidina ali zrelega mersacidina.
SI9500270A 1994-09-12 1995-09-01 Rekombinantni mersacidin in postopek za izdelavo SI9500270B (sl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94114298A EP0700998B1 (en) 1994-09-12 1994-09-12 Recombinant mersacidin and a method for production

Publications (2)

Publication Number Publication Date
SI9500270A SI9500270A (en) 1996-04-30
SI9500270B true SI9500270B (sl) 2002-02-28

Family

ID=8216276

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9500270A SI9500270B (sl) 1994-09-12 1995-09-01 Rekombinantni mersacidin in postopek za izdelavo

Country Status (19)

Country Link
US (1) US5667991A (sl)
EP (1) EP0700998B1 (sl)
JP (1) JPH0898695A (sl)
KR (1) KR100394289B1 (sl)
CN (1) CN1149287C (sl)
AT (1) ATE255165T1 (sl)
AU (1) AU696450B2 (sl)
CA (1) CA2157975C (sl)
CZ (1) CZ285741B6 (sl)
DE (1) DE69433357T2 (sl)
DK (1) DK0700998T3 (sl)
ES (1) ES2207636T3 (sl)
FI (1) FI120100B (sl)
HU (1) HU216619B (sl)
IL (1) IL115242A0 (sl)
NZ (1) NZ272960A (sl)
PT (1) PT700998E (sl)
RU (1) RU2198924C2 (sl)
SI (1) SI9500270B (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6775320B1 (en) 1999-03-12 2004-08-10 Aware, Inc. Method and a multi-carrier transceiver supporting dynamic switching between active application sets
EP1161820B1 (en) * 1999-03-12 2006-04-19 Aware, Inc. Seamless rate adaptive multicarrier modulation system and protocols
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
GB0406870D0 (en) * 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
US7592308B2 (en) 2004-03-26 2009-09-22 Novacta Biosystems Limited F3W variants of the lantibiotic mersacidin and its use
EP1928900A1 (en) * 2005-09-27 2008-06-11 Novacta Biosystems Limited Variants of the lantibiotic mersacidin and their use
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
RU2441915C9 (ru) * 2007-08-03 2012-06-20 Сентинелла Фармасьютикалс, Инк. Гены и белки для биосинтеза лантибиотика 107891
CA2720173A1 (en) * 2008-04-02 2009-10-08 Sanofi-Aventis Highly bridged peptides from actinomadura namibiensis
RU2506272C2 (ru) * 2008-11-24 2014-02-10 Сентинелла Фармасьютикалз, Инк. ("Сентинелла") Лантибиотические карбоксиамидные производные с усиленной антибактериальной активностью
SG172944A1 (en) 2009-01-14 2011-08-29 Novacta Biosystems Ltd Deoxyactagardine derivatives
EP2393829A1 (en) 2009-02-04 2011-12-14 Novacta Biosystems Limited Actagardine derivatives
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
BR112021015289A2 (pt) 2019-02-05 2021-10-05 Elanco Us Inc. Composição, método para melhorar saúde animal, e, método para tratar, melhorar os efeitos ou prevenir a enterite necrótica em aves
CN111235119B (zh) * 2020-03-05 2021-11-23 苏州十一方生物科技有限公司 一种融合抗菌蛋白的制备及应用
CN114457102B (zh) * 2022-02-24 2023-12-26 重庆市畜牧科学院 用于编码分泌型Mersacidin的基因表达盒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218101A (en) * 1988-07-05 1993-06-08 The University Of Maryland Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
IN167138B (sl) * 1988-08-17 1990-09-01 Hoechst India

Also Published As

Publication number Publication date
HU9502643D0 (en) 1995-11-28
CN1131192A (zh) 1996-09-18
AU3055495A (en) 1996-03-28
CA2157975C (en) 2008-11-18
HUT73800A (en) 1996-09-30
US5667991A (en) 1997-09-16
NZ272960A (en) 1996-05-28
FI120100B (fi) 2009-06-30
KR100394289B1 (ko) 2003-10-22
FI954220L (fi) 1996-03-13
PT700998E (pt) 2004-03-31
HU216619B (hu) 1999-07-28
CN1149287C (zh) 2004-05-12
IL115242A0 (en) 1995-12-31
EP0700998B1 (en) 2003-11-26
JPH0898695A (ja) 1996-04-16
RU2198924C2 (ru) 2003-02-20
FI954220A0 (fi) 1995-09-08
EP0700998A1 (en) 1996-03-13
DE69433357T2 (de) 2004-09-09
SI9500270A (en) 1996-04-30
CZ231895A3 (en) 1996-03-13
CA2157975A1 (en) 1996-03-13
ATE255165T1 (de) 2003-12-15
CZ285741B6 (cs) 1999-10-13
AU696450B2 (en) 1998-09-10
KR960010863A (ko) 1996-04-20
ES2207636T3 (es) 2004-06-01
DE69433357D1 (de) 2004-01-08
DK0700998T3 (da) 2004-03-29

Similar Documents

Publication Publication Date Title
SI9500270B (sl) Rekombinantni mersacidin in postopek za izdelavo
WO1999020766A3 (en) NOVEL MODIFIED NUCLEIC ACID SEQUENCES AND METHODS FOR INCREASING mRNA LEVELS AND PROTEIN EXPRESSION IN CELL SYSTEMS
AU6893587A (en) Recombinant dna sequences, vectors containing them and method for the use thereof
IL173399A0 (en) Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
ES2181900T3 (es) Clonacion recombinante in vitro usanto sitios de recombinacion por ingenieria genetica.
AU3178499A (en) Transfer method for specific cellular localisation of nucleic acids
US5024943A (en) Regulatory region cloning and analysis plasmid for bacillus
IL88151A (en) Interleukin-7 protein, dna sequences encoding it, its preparation and compositions containing it
WO2003040370A1 (en) Weed controller metabolism proteins, genes thereof and use of the same
EP0139501A3 (en) The manufacture and expression of genes for thaumatin
ATE369876T1 (de) Nukleotid- und aminosäuresequenzen gb, gc und gd des herpesvirus des hundes und ihre verwendungen
DE69828874D1 (de) Zusammensetzungen und verfahren zur eliminierung unerwünschter zellen
AU5653294A (en) Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene
JPS6037990A (ja) Ｇｒｆ前駆体をコードするｄｎａ
CA2628354A1 (en) Organic cation transporter genes
WO2002010384A1 (en) Genes encoding proteins capable of regenerating luciferin, recombinant dna and process for producing protein capable of regenerating luciferin
EP0955370A3 (en) DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
WO2023245010A3 (en) Crispr-transposon systems for dna modification
Ellis The search for plant messenger RNA
Bujard et al. Insertion of transcriptional elements outside the replication region can interfere with replication, maintenance, and stability of ColE1-derived plasmids
WO2002016601A3 (en) Microorganisms and assays for the identification of antibiotics
EP0897984A3 (en) D-Sorbitol dehydrogenase gene
Janda et al. Preparation and sequencing of the cloacin fragment of Streptomycesaureofaciens 16S RNA
AU2001253258A1 (en) Human trp-like calcium channel protein-2 (tlcc-2)
JPH0779782A (ja) シネココッカスｐｃｃ７００２由来ルビスコ（リブロース １，５−ビスホスフェート カルボキシラーゼ／オキシゲナーゼ）遺伝子のプロモーター配列

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20140429